Skip to main content
Displaying 1 - 5 of 5
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
5
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
5
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
5
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
5
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
5
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" - EASL Congress 2023
View
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy